Clinical Trial Update: Neuronavigation Guided iTBS With Personalized Target for Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating neuronavigation-guided intermittent theta-burst stimulation with personalized target for depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Xijing Hospital | Conditions: Depression | Phase 2 | Status: COMPLETED